VIPER: Veterans Integrated Pain Evaluation Research
VIPER
VIPER
Sponsor study identifier
observational
124
1 country
1
Study Start
January 2012
Actual (reported)Primary Completion
October 2013
Actual (reported)Study Completion
February 2017
Actual (reported)The purpose of the study is to learn about the causes of different types of pain that can occur in people who have had an amputation. By gathering information through blood tests, photographs, a nerve test, and questionnaires, we hope to de-code how each individual's special characteristics affect the type and amount of pain they experience in their amputated limb.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2017
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2012
Actual (reported)October 17, 2012
Actual (reported)October 29, 2012
Actual (reported)October 2013
Actual (reported)February 2017
Actual (reported)Proteomics
To determine which proteins represent circulating qualitative and quantitative biomarkers of pain.
1 day
Male and female active duty military personnel age 18 years and older presenting with the diagnosis of amputation of 1 limb in the previous 18 months. At least 3 months must have passed since the first amputation procedure.
Walter Reed National Military Medical Center
Bethesda, Maryland, 20889, United States
Blood draw will consist of, two BD™ P100 tubes (2x8.5mL=17mL) where the plasma will be separated by centrifuge then placed in a -80ºC freezer. Two RNA tubes (2 x 2.5mL=5mL) and one DNA tube (8.5mL) will be place first, in a -20ºC freezer for 24-36 hours then moved to a -80ºC freezer. All the blood samples will remain in a -80ºC freezer at the Department of Clinical Investigation(DCI) laboratory until they are sent to Duke University after every 8 subjects.
124 participants (actual enrollment reported by the registry).
First Submitted
October 17, 2012
First Posted
October 29, 2012
Study Start
January 2012
Actual (reported)Remote Ischemic Preconditioning Mechanism Study
Contact the study team to confirm eligibility.
Primary Completion
October 2013
Actual (reported)Study Completion
February 2017
Actual (reported)Last Updated
August 14, 2019
Record last verified: 2019-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: